Pamela Wapnick

Chief Financial Officer

Chief Financial Officer at Metagenomi Therapeutics, Inc., filing insider transactions on 2026-09-08.

Total Purchases

—

0 transactions

Total Sales

$2K

1 transaction

Companies Traded

1 total filings

Active Since

2026-09-08

Last: 2026-09-08

Companies

Metagenomi Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-08	MGX	Sale	1,911	$1.16	$2K	206.6K	SEC ↗